Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Liver-directed gene transfer vectors

N Ferry1, J M Heard

  • 1Laboratoire de Thérapie Génique, Nantes, France.

Human Gene Therapy
|October 6, 1998
PubMed
Summary
This summary is machine-generated.

Liver-directed gene therapy aims for stable transgene expression in hepatocytes. Current vectors show limitations, but newer systems like adeno-associated vectors offer promise for genetic disease treatment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Human and Bovine Tuberculosis.

The Journal of comparative medicine and surgery·2022
Same author

The impact of COVID-19 on rare metabolic patients and healthcare providers: results from two MetabERN surveys.

Orphanet journal of rare diseases·2020
Same author

[Lower bodylift after massive weight loss: Retrospective study of satisfaction, complications and quality of life. About 76 patients over 4years].

Annales de chirurgie plastique et esthetique·2016
Same author

Sustained inhibition of hepatitis B virus replication in vivo using RNAi-activating lentiviruses.

Gene therapy·2014
Same author

In situ retrovirus-mediated gene transfer into the liver.

Methods in molecular medicine·2014
Same author

In the rat liver, Adenoviral gene transfer efficiency is comparable to AAV.

Gene therapy·2013
Same journal

Genome Editing for Familial Hemophagocytic Lymphohistiocytosis: Design Principles, Challenges, and Translational Perspectives.

Human gene therapy·2026
Same journal

Lilly, Ascidian Launch Up-to-$1.9B RNA Exon Editor Collaboration.

Human gene therapy·2026
Same journal

Hyperthermia-Enhanced Adeno-Associated Virus Gene Therapy: Mechanisms, Delivery Technologies, and Translational Potential.

Human gene therapy·2026
Same journal

Adeno-Associated Virus Gene Therapy Translation: Lessons from Early Regulatory Meetings.

Human gene therapy·2026
Same journal

In Remembrance of Professor Zelig Eshhar: <i>A Life Committed to CAR-T</i>.

Human gene therapy·2026
Same journal

<i>In Vivo</i> Genome Editing Approach to Disrupt Hydroxyacid Oxidase 1 for the Treatment of Primary Hyperoxaluria Type 1.

Human gene therapy·2026
See all related articles

Area of Science:

  • Hepatology
  • Gene Therapy
  • Molecular Biology

Background:

  • Liver-directed gene therapy seeks stable therapeutic transgene expression in hepatocytes for genetic diseases.
  • Evaluating current gene transfer vector systems for clinical relevance in liver therapy is crucial.

Purpose of the Study:

  • To review and analyze various liver-directed gene transfer procedures and vector systems.
  • To discuss the performances and limitations of available vectors for clinical applications in liver gene therapy.

Main Methods:

  • Literature review of liver-directed gene transfer studies.
  • Analysis of naked DNA, nonviral, retrovirus, and adenovirus vector systems.
  • Assessment of emerging vectors: gutless adenovirus, adeno-associated, and lentivirus vectors.

Related Experiment Videos

Main Results:

  • Naked DNA and nonviral vectors yield transient expression in limited cells.
  • Retrovirus vectors require hepatocyte division, limiting clinical use.
  • First-generation adenovirus vectors are efficient but trigger immune responses, causing cell rejection.

Conclusions:

  • Newer vector systems, including gutless adenovirus, adeno-associated, and lentivirus vectors, show promise.
  • Further documentation and validation are needed to confirm the relevance of these novel systems for liver-directed gene therapy.